Foto: Alexandra Pekala

A Health Check For The Brain

Our cognitive functions change over time and are affected by depression, stress, ADHD, fatigue syndrome and dementia, and many other factors. However, the brain is rarely tested when you visit your doctor, because traditional methods are very time-consuming.

Mindmore measures important cognitive functions such as memory, short-term memory, word comprehension, concentration, reaction time, mental pace and problem-solving skills. The company has combined 24 proven evidence-based tests of cognitive function into one digital application. A sound knowledge of a patient’s cognitive state and development helps doctors, psychologists and other health personnel to do a better and more effective job of helping them.

Mindmore has experienced rapid growth in Sweden, and plan to scale further nationally and then to Europe. 

First Direct Investment In Sweden

Ferd shares Mindmore’s vision that cognitive testing should be available to many people and sees a great potential in the company, both in terms of the social effect, commercial potential, and the opportunity to scale internationally.

Mindmore is our first direct investment in Sweden. We have invested through a convertible loan and support the entrepreneur and the company with our dedicated business developers, including on Impact Management and Measurement (IMM).

Impact Performance 2025

2 826

Number of tests within specialist, primary and occupational health services.

Perceived clinical utility
87%
Clinicians who believe the tests make brain health visible
87%
Contributes to patients gaining a better understanding of their condition
100%
More person-centred treatment
50%

How the figures were sourced:

Number of tests in primary, specialist and occupational health services: Number of tests administered by clinicians in specialist health services, primary health services, occupational health services (OHS) and ADHD clinics. Does not include tests in connection with studies and research.

Perceived clinical utility: Proportion of clinicians who experience clinical utility from Mindmore in their work, based on the question: “I experience that the use of Mindmore’s service provides clinical added value in my work.” The response scale runs from 1–4, where 3 and 4 are considered a positive outcome and 1 and 2 a negative outcome. The figures are based on a user survey conducted in December–January 2025/2026, answered by 15 clinicians in primary health services and occupational health services.

Clinicians who believe the tests make brain health visible: Proportion of clinicians who agree that the testing provides clinicians with detailed information about important aspects of the patient that might otherwise present as other symptoms. The responses are based on the same survey (n = 15).

Contributes to patients gaining a better understanding of their condition: Proportion of clinicians who agree that patients, with the help of Mindmore, have gained a better understanding of their condition and cognitive function. The responses are based on the same survey (n = 15).

More person-centred treatment: Proportion of clinicians who agree that testing with Mindmore helps them plan interventions and provides more person-centred treatment. The responses are based on the same survey (n = 15).

About the company

Established: 2017
Founder: Sara Wallén
Legal Structure: Private Limited Company